{"id":10205,"date":"2023-11-17T19:33:13","date_gmt":"2023-11-17T19:33:13","guid":{"rendered":"https:\/\/medicalcriteria.com\/web\/?p=10205"},"modified":"2025-12-30T19:12:12","modified_gmt":"2025-12-30T19:12:12","slug":"imwg-myeloma-and-related-plasma-cell-disorders","status":"publish","type":"post","link":"https:\/\/medicalcriteria.com\/web\/es\/imwg-myeloma-and-related-plasma-cell-disorders\/","title":{"rendered":"Criterios Diagn\u00f3stico IMWG para Mieloma M\u00faltiple y Trastornos Relacionados de las C\u00e9lulas Plasm\u00e1ticas"},"content":{"rendered":"<div class=\"7ca9444b8380138fe077da07353677a4\" data-index=\"1\" style=\"float: none; margin:0px 0 0px 0; text-align:center;\">\n<script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js\"><\/script>\r\n<!-- MC 2019- Horizontal -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-0127150553352455\"\r\n     data-ad-slot=\"3806776041\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script>\n<\/div>\n<p>Las neoplasias de c\u00e9lulas plasm\u00e1ticas, incluido el mieloma m\u00faltiple (MM) y las neoplasias de c\u00e9lulas B diferenciadas terminales relacionadas, se caracterizan por la secreci\u00f3n de inmunoglobulina monoclonal y el desarrollo gradual a partir de una proliferaci\u00f3n de c\u00e9lulas plasm\u00e1ticas B clonales preneopl\u00e1sicas y\/o denominada gammapat\u00eda monoclonal de significado indeterminado (GMSI). El diagn\u00f3stico de estos trastornos requiere la integraci\u00f3n de caracter\u00edsticas cl\u00ednicas, de laboratorio y morfol\u00f3gicas.<!--more--><\/p>\n<p><strong>Criterios diagn\u00f3stico IMWG sobre mieloma para mieloma m\u00faltiple y trastornos relacionados de las c\u00e9lulas plasm\u00e1ticas<\/strong><\/p>\n<table style=\"border-collapse: collapse; width: 100%; height: 1848px;\" border=\"1\">\n<tbody>\n<tr style=\"height: 24px;\">\n<td style=\"width: 22.0569%; height: 24px;\"><strong>Trastorno<\/strong><\/td>\n<td style=\"width: 77.9431%; height: 24px;\"><strong>Definici\u00f3n de enfermedad<\/strong><\/td>\n<\/tr>\n<tr style=\"height: 168px;\">\n<td style=\"width: 22.0569%; height: 168px;\"><strong>GMSI No-IgM<\/strong><\/td>\n<td style=\"width: 77.9431%; height: 168px;\">Se deben cumplir los tres criterios:<\/p>\n<ul>\n<li>Prote\u00edna monoclonal s\u00e9rica (tipo no IgM) &lt; 3 g\/dl<\/li>\n<li>C\u00e9lulas plasm\u00e1ticas clonales de m\u00e9dula \u00f3sea &lt; 10%*<\/li>\n<li>Ausencia de da\u00f1o en los \u00f3rganos terminales, como caracter\u00edsticas CRAB, que puedan atribuirse al trastorno proliferativo de las c\u00e9lulas plasm\u00e1ticas.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 168px;\">\n<td style=\"width: 22.0569%; height: 168px;\"><strong>MM Asintom\u00e1tico<\/strong><\/td>\n<td style=\"width: 77.9431%; height: 168px;\">Deben cumplirse ambos criterios:<\/p>\n<ul>\n<li>Prote\u00edna monoclonal s\u00e9rica (IgG o IgA) \u2265 3 g\/dl, o prote\u00edna monoclonal urinaria \u2265 500 mg cada 24 h y\/o c\u00e9lulas plasm\u00e1ticas clonales de m\u00e9dula \u00f3sea 10%-60%<\/li>\n<li>Ausencia de eventos definitorios de mieloma o amiloidosis<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 528px;\">\n<td style=\"width: 22.0569%; height: 528px;\"><strong>MM<\/strong><\/td>\n<td style=\"width: 77.9431%; height: 528px;\">Deben cumplirse ambos criterios:<\/p>\n<ul>\n<li>C\u00e9lulas plasm\u00e1ticas clonales de m\u00e9dula \u00f3sea \u2265 10% o plasmocitoma \u00f3seo o extramedular comprobado por biopsia<\/li>\n<li>Uno o m\u00e1s de los siguientes eventos que definen el mieloma:\n<ul>\n<li>Evidencia de da\u00f1o en \u00f3rganos terminales que puede atribuirse al trastorno proliferativo de c\u00e9lulas plasm\u00e1ticas subyacente, espec\u00edficamente:\n<ul>\n<li>Hipercalcemia: calcio s\u00e9rico &gt; 0,25 mmol\/L (&gt; 1 mg\/dL) superior al l\u00edmite superior normal o &gt; 2,75 mmol\/L (&gt; 11 mg\/dL)<\/li>\n<li>Insuficiencia renal: aclaramiento de creatinina &lt; 40 ml\/min o creatinina s\u00e9rica &gt; 177 mmol\/L (&gt; 2 mg\/dL)<\/li>\n<li>Anemia: valor de hemoglobina &gt; 2 g\/dL por debajo del l\u00edmite inferior normal, o valor de hemoglobina &lt; 10 g\/dL<\/li>\n<li>Lesiones \u00f3seas: una o m\u00e1s lesiones osteol\u00edticas en radiograf\u00eda esquel\u00e9tica, TC o PET-CT<\/li>\n<\/ul>\n<\/li>\n<li>Porcentaje de c\u00e9lulas plasm\u00e1ticas clonales de m\u00e9dula \u00f3sea \u2265 60%<\/li>\n<li>Compromiso: relaci\u00f3n de CLL s\u00e9ricas no involucradas \u2265 100 (el nivel de CLL involucradas debe ser \u2265 100 mg\/L)<\/li>\n<li>&gt; 1 lesi\u00f3n focal en estudios de resonancia magn\u00e9tica (al menos 5 mm de tama\u00f1o)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 192px;\">\n<td style=\"width: 22.0569%; height: 192px;\"><strong>GMSI IgM<\/strong><\/td>\n<td style=\"width: 77.9431%; height: 192px;\">Se deben cumplir los tres criterios:<\/p>\n<ul>\n<li>Prote\u00edna monoclonal IgM s\u00e9rica &lt; 3 g\/dl<\/li>\n<li>Infiltraci\u00f3n linfoplasmoc\u00edtica de m\u00e9dula \u00f3sea &lt; 10%<\/li>\n<li>No hay evidencia de anemia, s\u00edntomas constitucionales, hiperviscosidad, linfadenopat\u00eda o hepatoesplenomegalia que puedan atribuirse al trastorno linfoproliferativo subyacente.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 288px;\">\n<td style=\"width: 22.0569%; height: 288px;\"><strong>GMSI de cadenas livianas<\/strong><\/td>\n<td style=\"width: 77.9431%; height: 288px;\">Se deben cumplir todos los criterios:<\/p>\n<ul>\n<li>Relaci\u00f3n de CLL anormal (&lt; 0,26 o &gt; 1,65)<\/li>\n<li>Aumento del nivel de la cadena ligera involucrada apropiada (aumento de CLL kappa en pacientes con una proporci\u00f3n &gt; 1,65 y aumento de CLL lambda en pacientes con una proporci\u00f3n &lt; 0,26)<\/li>\n<li>Sin expresi\u00f3n de cadenas pesadas de inmunoglobulinas en la inmunofijaci\u00f3n<\/li>\n<li>Ausencia de da\u00f1o en \u00f3rganos terminales que pueda atribuirse al trastorno proliferativo de c\u00e9lulas plasm\u00e1ticas.<\/li>\n<li>C\u00e9lulas plasm\u00e1ticas clonales de m\u00e9dula \u00f3sea &lt; 10%<\/li>\n<li>Prote\u00edna monoclonal urinaria &lt; 500 mg\/24 h<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 240px;\">\n<td style=\"width: 22.0569%; height: 240px;\"><strong>Plasmacitoma solitario<\/strong><\/td>\n<td style=\"width: 77.9431%; height: 240px;\">Se deben cumplir los cuatro criterios:<\/p>\n<ul>\n<li>Lesi\u00f3n solitaria de hueso o tejido blando comprobada por biopsia con evidencia de c\u00e9lulas plasm\u00e1ticas clonales<\/li>\n<li>M\u00e9dula \u00f3sea normal sin evidencia de c\u00e9lulas plasm\u00e1ticas clonales<\/li>\n<li>Estudio esquel\u00e9tico normal y resonancia magn\u00e9tica (o tomograf\u00eda computarizada) de la columna y la pelvis (excepto la lesi\u00f3n solitaria primaria)<\/li>\n<li>Ausencia de da\u00f1o en los \u00f3rganos terminales, como caracter\u00edsticas CRAB, que puedan atribuirse a un trastorno proliferativo de c\u00e9lulas linfoplasm\u00e1ticas.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 240px;\">\n<td style=\"width: 22.0569%; height: 240px;\"><strong>Plasmacitoma solitario con m\u00ednima afectaci\u00f3n de la m\u00e9dula**<\/strong><\/td>\n<td style=\"width: 77.9431%; height: 240px;\">Se deben cumplir los cuatro criterios:<\/p>\n<ul>\n<li>Lesi\u00f3n solitaria de hueso o tejido blando comprobada por biopsia con evidencia de c\u00e9lulas plasm\u00e1ticas clonales<\/li>\n<li>C\u00e9lulas plasm\u00e1ticas clonales de m\u00e9dula \u00f3sea &lt; 10%<\/li>\n<li>Estudio esquel\u00e9tico normal y resonancia magn\u00e9tica (o tomograf\u00eda computarizada) de la columna y la pelvis (excepto la lesi\u00f3n solitaria primaria)<\/li>\n<li>Ausencia de da\u00f1o en los \u00f3rganos terminales, como caracter\u00edsticas CRAB, que puedan atribuirse a un trastorno proliferativo de c\u00e9lulas linfoplasm\u00e1ticas.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Abreviaturas: GMSI, gammapat\u00eda monoclonal de significado indeterminado; Caracter\u00edsticas de CRAB, hipercalcemia, insuficiencia renal, anemia y lesiones \u00f3seas; MM, mieloma m\u00faltiple; CLL, cadenas livianas libres; SMM, mieloma m\u00faltiple latente.<\/p>\n<p>*Un examen de m\u00e9dula \u00f3sea se puede diferir en pacientes con GMSI de bajo riesgo (tipo IgG, prote\u00edna M &lt; 15 g\/l, relaci\u00f3n CLL normal) en quienes no hay caracter\u00edsticas cl\u00ednicas relacionadas con el mieloma.<br \/>\n**El plasmocitoma solitario con 10% o m\u00e1s de c\u00e9lulas plasm\u00e1ticas clonales se considera MM.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Bibliograf\u00eda:<\/strong><\/p>\n<ol>\n<li>Fend F, Dogan A, Cook JR. Plasma cell neoplasms and related entities-evolution in diagnosis and classification. Virchows Arch. 2023 Jan;482(1):163-177. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36414803\/\" target=\"_blank\" rel=\"noopener\">[Medline]<\/a><\/li>\n<li>Rajkumar SV. Updated Diagnostic Criteria and Staging System for Multiple Myeloma. Am Soc Clin Oncol Educ Book. 2016;35:e418-23. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27249749\/\" target=\"_blank\" rel=\"noopener\">[Medline]<\/a><\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p>Creado Nov 14, 2023.<\/p>\n\n<div style=\"font-size: 0px; height: 0px; line-height: 0px; margin: 0; padding: 0; clear: both;\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Las neoplasias de c\u00e9lulas plasm\u00e1ticas, incluido el mieloma m\u00faltiple (MM) y las neoplasias de c\u00e9lulas B diferenciadas terminales relacionadas, se caracterizan por la secreci\u00f3n de inmunoglobulina monoclonal y el desarrollo gradual a partir de una proliferaci\u00f3n de c\u00e9lulas plasm\u00e1ticas B clonales preneopl\u00e1sicas y\/o denominada gammapat\u00eda monoclonal de significado indeterminado (GMSI). El diagn\u00f3stico de estos trastornos [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"no","_lmt_disable":"no","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[171],"tags":[757,756,16,15,14,13,939,2015,755,469,754,752,758,1563],"class_list":["post-10205","post","type-post","status-publish","format-standard","hentry","category-hematology","tag-cell","tag-celulas","tag-criteria","tag-criterios","tag-diagnostic","tag-diagnostico","tag-disorders","tag-imwg","tag-mieloma","tag-multiple","tag-myeloma","tag-plasma","tag-plasmaticas","tag-related"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Criterios Diagn\u00f3stico IMWG para Mieloma M\u00faltiple y Trastornos Relacionados de las C\u00e9lulas Plasm\u00e1ticas - MedicalCRITERIA.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"[:es]Criterios Diagn\u00f3stico IMWG para Mieloma M\u00faltiple y Trastornos Relacionados de las C\u00e9lulas Plasm\u00e1ticas[:en]IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders[:] - MedicalCRITERIA.com\" \/>\n<meta property=\"og:description\" content=\"Las neoplasias de c\u00e9lulas plasm\u00e1ticas, incluido el mieloma m\u00faltiple (MM) y las neoplasias de c\u00e9lulas B diferenciadas terminales relacionadas, se caracterizan por la secreci\u00f3n de inmunoglobulina monoclonal y el desarrollo gradual a partir de una proliferaci\u00f3n de c\u00e9lulas plasm\u00e1ticas B clonales preneopl\u00e1sicas y\/o denominada gammapat\u00eda monoclonal de significado indeterminado (GMSI). El diagn\u00f3stico de estos trastornos [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/\" \/>\n<meta property=\"og:site_name\" content=\"MedicalCRITERIA.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/medicalcriteria\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-17T19:33:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-30T19:12:12+00:00\" \/>\n<meta name=\"author\" content=\"Guillermo Firman\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Guillermo Firman\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/imwg-myeloma-and-related-plasma-cell-disorders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/imwg-myeloma-and-related-plasma-cell-disorders\\\/\"},\"author\":{\"name\":\"Guillermo Firman\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#\\\/schema\\\/person\\\/ead6734a2f20659131388ba822c7078c\"},\"headline\":\"Criterios Diagn\u00f3stico IMWG para Mieloma M\u00faltiple y Trastornos Relacionados de las C\u00e9lulas Plasm\u00e1ticas\",\"datePublished\":\"2023-11-17T19:33:13+00:00\",\"dateModified\":\"2025-12-30T19:12:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/imwg-myeloma-and-related-plasma-cell-disorders\\\/\"},\"wordCount\":1521,\"publisher\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#organization\"},\"keywords\":[\"Cell\",\"celulas\",\"Criteria\",\"criterios\",\"Diagnostic\",\"diagnostico\",\"Disorders\",\"IMWG\",\"mieloma\",\"Multiple\",\"Myeloma\",\"Plasma\",\"plasmaticas\",\"Related\"],\"articleSection\":[\"Hematology\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/imwg-myeloma-and-related-plasma-cell-disorders\\\/\",\"url\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/imwg-myeloma-and-related-plasma-cell-disorders\\\/\",\"name\":\"[:es]Criterios Diagn\u00f3stico IMWG para Mieloma M\u00faltiple y Trastornos Relacionados de las C\u00e9lulas Plasm\u00e1ticas[:en]IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders[:] - MedicalCRITERIA.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#website\"},\"datePublished\":\"2023-11-17T19:33:13+00:00\",\"dateModified\":\"2025-12-30T19:12:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/imwg-myeloma-and-related-plasma-cell-disorders\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/imwg-myeloma-and-related-plasma-cell-disorders\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/imwg-myeloma-and-related-plasma-cell-disorders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#website\",\"url\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/\",\"name\":\"MedicalCRITERIA.com\",\"description\":\"Unifying Concepts\",\"publisher\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#organization\",\"name\":\"MedicalCRITERIA.com\",\"alternateName\":\"Criterios M\u00e9dicos\",\"url\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/cropped-mc_1024x500.png\",\"contentUrl\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/cropped-mc_1024x500.png\",\"width\":600,\"height\":257,\"caption\":\"MedicalCRITERIA.com\"},\"image\":{\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/medicalcriteria\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/medicalcriteria.com\\\/web\\\/#\\\/schema\\\/person\\\/ead6734a2f20659131388ba822c7078c\",\"name\":\"Guillermo Firman\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g\",\"caption\":\"Guillermo Firman\"},\"sameAs\":[\"http:\\\/\\\/MedicalCRITERIA.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"[:es]Criterios Diagn\u00f3stico IMWG para Mieloma M\u00faltiple y Trastornos Relacionados de las C\u00e9lulas Plasm\u00e1ticas[:en]IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders[:] - MedicalCRITERIA.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/","og_locale":"es_ES","og_type":"article","og_title":"[:es]Criterios Diagn\u00f3stico IMWG para Mieloma M\u00faltiple y Trastornos Relacionados de las C\u00e9lulas Plasm\u00e1ticas[:en]IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders[:] - MedicalCRITERIA.com","og_description":"Las neoplasias de c\u00e9lulas plasm\u00e1ticas, incluido el mieloma m\u00faltiple (MM) y las neoplasias de c\u00e9lulas B diferenciadas terminales relacionadas, se caracterizan por la secreci\u00f3n de inmunoglobulina monoclonal y el desarrollo gradual a partir de una proliferaci\u00f3n de c\u00e9lulas plasm\u00e1ticas B clonales preneopl\u00e1sicas y\/o denominada gammapat\u00eda monoclonal de significado indeterminado (GMSI). El diagn\u00f3stico de estos trastornos [&hellip;]","og_url":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/","og_site_name":"MedicalCRITERIA.com","article_publisher":"https:\/\/www.facebook.com\/medicalcriteria\/","article_published_time":"2023-11-17T19:33:13+00:00","article_modified_time":"2025-12-30T19:12:12+00:00","author":"Guillermo Firman","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Guillermo Firman","Tiempo de lectura":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/#article","isPartOf":{"@id":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/"},"author":{"name":"Guillermo Firman","@id":"https:\/\/medicalcriteria.com\/web\/#\/schema\/person\/ead6734a2f20659131388ba822c7078c"},"headline":"Criterios Diagn\u00f3stico IMWG para Mieloma M\u00faltiple y Trastornos Relacionados de las C\u00e9lulas Plasm\u00e1ticas","datePublished":"2023-11-17T19:33:13+00:00","dateModified":"2025-12-30T19:12:12+00:00","mainEntityOfPage":{"@id":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/"},"wordCount":1521,"publisher":{"@id":"https:\/\/medicalcriteria.com\/web\/#organization"},"keywords":["Cell","celulas","Criteria","criterios","Diagnostic","diagnostico","Disorders","IMWG","mieloma","Multiple","Myeloma","Plasma","plasmaticas","Related"],"articleSection":["Hematology"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/","url":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/","name":"[:es]Criterios Diagn\u00f3stico IMWG para Mieloma M\u00faltiple y Trastornos Relacionados de las C\u00e9lulas Plasm\u00e1ticas[:en]IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders[:] - MedicalCRITERIA.com","isPartOf":{"@id":"https:\/\/medicalcriteria.com\/web\/#website"},"datePublished":"2023-11-17T19:33:13+00:00","dateModified":"2025-12-30T19:12:12+00:00","breadcrumb":{"@id":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medicalcriteria.com\/web\/imwg-myeloma-and-related-plasma-cell-disorders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/medicalcriteria.com\/web\/"},{"@type":"ListItem","position":2,"name":"IMWG Diagnostic Criteria for Multiple Myeloma and Related Plasma Cell Disorders"}]},{"@type":"WebSite","@id":"https:\/\/medicalcriteria.com\/web\/#website","url":"https:\/\/medicalcriteria.com\/web\/","name":"MedicalCRITERIA.com","description":"Unifying Concepts","publisher":{"@id":"https:\/\/medicalcriteria.com\/web\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicalcriteria.com\/web\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/medicalcriteria.com\/web\/#organization","name":"MedicalCRITERIA.com","alternateName":"Criterios M\u00e9dicos","url":"https:\/\/medicalcriteria.com\/web\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/medicalcriteria.com\/web\/#\/schema\/logo\/image\/","url":"https:\/\/medicalcriteria.com\/web\/wp-content\/uploads\/2025\/03\/cropped-mc_1024x500.png","contentUrl":"https:\/\/medicalcriteria.com\/web\/wp-content\/uploads\/2025\/03\/cropped-mc_1024x500.png","width":600,"height":257,"caption":"MedicalCRITERIA.com"},"image":{"@id":"https:\/\/medicalcriteria.com\/web\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/medicalcriteria\/"]},{"@type":"Person","@id":"https:\/\/medicalcriteria.com\/web\/#\/schema\/person\/ead6734a2f20659131388ba822c7078c","name":"Guillermo Firman","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/24f0f68ba780b5b240680962755c6f75e6116e6667394a46e38b7b8fd0a62e9f?s=96&d=mm&r=g","caption":"Guillermo Firman"},"sameAs":["http:\/\/MedicalCRITERIA.com"]}]}},"modified_by":"Guillermo Firman","_links":{"self":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/10205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/comments?post=10205"}],"version-history":[{"count":11,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/10205\/revisions"}],"predecessor-version":[{"id":10222,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/10205\/revisions\/10222"}],"wp:attachment":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/media?parent=10205"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/categories?post=10205"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/tags?post=10205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}